Skip to content

Baxter International BAX Impairment Charges

Impairment Charges at other companies

Medtronic logo
MedtronicMDT
$0
BrightSpring Health Services, Inc. logo
BrightSpring Health Services, Inc.BTSG
$6.1M+11.9%
West Pharmaceutical Services logo
West Pharmaceutical ServicesWST
$300K0.0%
McKesson logo
McKessonMCK
$6M-14.3%
Nordson logo
NordsonNDSN
$3.14M
Viatris logo
ViatrisVTRS
$0-100%

Segments

By product

See full
Front Line Care$485M+14.1%

Other financials

Income statement

See full
Revenue$2.7B+2.9%
Gross profit$891.0M+3.5%
Operating income$66.0M+13.8%
Net income-$15.0M-112%
EPS (diluted)-$0.03-112%

Balance sheet

See full
Cash & equivalents$2.0B-12.1%
Total debt$224.0M-8.9%
Total equity$6.0B-14.7%
Total assets$19.8B-6.8%

Cash flow

See full
Operating cash flow$213.0M+210%
CapEx$128.3M+15.0%
Free cash flow$83.0M-42.1%

Valuation

See full
Market cap$10.27B-50.6%
Enterprise value$8.48B-55.6%
P/S0.9×-1.0×

Profitability

See full
Gross margin30.1%-5.9pp
Operating margin-2.7%
Net margin-9.7%+62.5pp
FCF margin3%-2.4pp

Returns & leverage

See full
Return on equity-16.7%-76.7pp
Debt / equity0.0×
Current ratio1.9×-0.2×

Where this comes from

Reported directly by Baxter International in its filing.

Tagged under the XBRL concept us-gaap:OtherAssetImpairmentCharges.

The official record: Baxter International’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →

Ask your AI about Baxter International's impairment charges.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Baxter International's impairment charges?
Baxter International (BAX) reported impairment charges of $0 in Q1 2026.
How has Baxter International's impairment charges changed year-over-year?
Baxter International's impairment charges decreased by 100.0% year-over-year, from $22M to $0.
What does impairment charges mean?
Non-cash charges taken when the value of an asset is reduced on the balance sheet.
How do you interpret impairment charges?
High or frequent charges suggest poor historical capital allocation or deteriorating business unit performance.
How does impairment charges compare across companies?
Often seen in companies that have recently completed large acquisitions or are undergoing strategic pivots.